71 related articles for article (PubMed ID: 2797560)
21. Women's experiences of cervical screening.
N Z Nurs J; 1987 Sep; 80(9):19-21. PubMed ID: 3696587
[No Abstract] [Full Text] [Related]
22. Economics of screening for cancer of the cervix.
Hicks S; Edwards D
N Z Med J; 1986 Nov; 99(814):916. PubMed ID: 3468422
[No Abstract] [Full Text] [Related]
23. New cervical screening legislation: access to clinical records.
Lewis H
N Z Med J; 2004 Apr; 117(1191):U829. PubMed ID: 15107891
[No Abstract] [Full Text] [Related]
24. [Screening of cervical cancer, false negative smears].
Vassilakos P; de Marval F; Muñoz M
Rev Med Suisse Romande; 1998 Jan; 118(1):97. PubMed ID: 9580199
[No Abstract] [Full Text] [Related]
25. Cervical cytology 1980 -- its place and value.
Duncan GR
N Z Med J; 1981 Feb; 93(678):119-22. PubMed ID: 6943454
[No Abstract] [Full Text] [Related]
26. Conventional Pap smears are unreliable.
Reid RI
Med J Aust; 1998 Mar; 168(5):252. PubMed ID: 9539907
[No Abstract] [Full Text] [Related]
27. HPV prevention and the promise of the new vaccines.
Allred S; Cox JT; Mahoney M
J Am Acad Nurse Pract; 2006; 18 Suppl 2():1-11. PubMed ID: 17474243
[No Abstract] [Full Text] [Related]
28. Economic aspects of screening for cervical cancer in New Zealand.
Bethwaite J; Rayner T; Bethwaite P
N Z Med J; 1986 Oct; 99(811):747-51. PubMed ID: 3464889
[TBL] [Abstract][Full Text] [Related]
29. The FocalPoint System: FocalPoint slide profiler and FocalPoint GS.
Kardos TF
Cancer; 2004 Dec; 102(6):334-9. PubMed ID: 15549692
[No Abstract] [Full Text] [Related]
30. A cervical cytology screening programme in the Thames area. Second and third years of study.
McIndoe WA
N Z Med J; 1966 Oct; 65(410):647-51. PubMed ID: 5224361
[No Abstract] [Full Text] [Related]
31. The Bethesda system and Pap smear screening.
Miller K
Am Fam Physician; 1995 Feb; 51(2):331-2. PubMed ID: 7840027
[No Abstract] [Full Text] [Related]
32. Overcoming Mâori women's resistance to cervical smears.
Lloyd L
Nurs N Z; 2006 Oct; 12(9):31. PubMed ID: 17112080
[No Abstract] [Full Text] [Related]
33. [The potentials for optimizing cervical screening].
Zlatkov V; Kostova P
Akush Ginekol (Sofiia); 1998; 37(2):45-9. PubMed ID: 9859538
[No Abstract] [Full Text] [Related]
34. Mass screening for cancer and precancerous conditions of cervix uteri. A preliminary report.
Messelt OT; Höeg K
Acta Cytol; 1967; 11(1):39-40. PubMed ID: 5230439
[No Abstract] [Full Text] [Related]
35. Evaluation of automated systems for the analysis of cervical smears.
Coleman DV
Cytopathology; 1998 Dec; 9(6):359-68. PubMed ID: 9861528
[No Abstract] [Full Text] [Related]
36. Changes to cervical screening in Australia: applying lessons learnt.
Farnsworth A
Med J Aust; 2014 Sep; 201(5):245-6. PubMed ID: 25163361
[No Abstract] [Full Text] [Related]
37. [Cervical cancer screening].
Lynge E
Ugeskr Laeger; 2002 Jan; 164(2):171-3. PubMed ID: 11831082
[No Abstract] [Full Text] [Related]
38. Cervical screening: making it better.
Quek SC; Singer A
Practitioner; 1999 Jun; 243(1599):441. PubMed ID: 10476562
[No Abstract] [Full Text] [Related]
39. Improving the coverage and quality of cervical screening: women's views.
Summers A; Fullard B
J Public Health Med; 1995 Sep; 17(3):277-81. PubMed ID: 8527179
[No Abstract] [Full Text] [Related]
40. A survey of Pap smear screening in upstate New York.
Howe HL; Bzduch H
N Y State J Med; 1986 Jun; 86(6):291-6. PubMed ID: 3461331
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
